Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serum ropivacaine concentrations after unilateral Pecs II block in breast cancer surgery
2019-004813-15Phase 4Completed
- Sponsor
- AZ Turnhout
- Start
- Sep 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropivacaine in breast cancer, sponsored by AZ Turnhout. Primary endpoints: Peak venous serum concentration of ropivacaine and Mean venous serum concentration of ropivacaine. Started Sep 2020; status: completed.
02
Drugs
ropivacaine
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2019-004813-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004813-15.